Metastatic atypical fibroxanthoma: the importance of structured reporting for cutaneous sarcoma-like tumour
Pathology · 2024
DOI: 10.1016/j.pathol.2024.02.011 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pathology, 2024. Verfasst von Megan Yap und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. Hauptthemen laut MEDLINE: Sarcoma, Skin Neoplasms. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
- PathWest Dermatopathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia; The University of Western Australia, Perth, WA, Australia.
- PathWest Dermatopathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia; The University of Western Australia, Perth, WA, Australia. Electronic address: Benjamin.wood@health.wa.gov.au.
Zitieren
APA
Yap, M., Harvey, N. T., Mesbah Ardakani, N., & Wood, B. A. (2024). Metastatic atypical fibroxanthoma: the importance of structured reporting for cutaneous sarcoma-like tumour. Pathology. https://doi.org/10.1016/j.pathol.2024.02.011
Vancouver
Yap M, Harvey NT, Mesbah Ardakani N, Wood BA. Metastatic atypical fibroxanthoma: the importance of structured reporting for cutaneous sarcoma-like tumour. Pathology. 2024. doi:10.1016/j.pathol.2024.02.011
BibTeX
@article{Yap2024,
author = {Yap, Megan and Harvey, Nathan T and Mesbah Ardakani, Nima and Wood, Benjamin A},
title = {Metastatic atypical fibroxanthoma: the importance of structured reporting for cutaneous sarcoma-like tumour},
journal = {Pathology},
year = {2024},
doi = {10.1016/j.pathol.2024.02.011}
}
EUVIMED